123 related articles for article (PubMed ID: 37419428)
21. MEK2 regulates ribonucleotide reductase activity through functional interaction with ribonucleotide reductase small subunit p53R2.
Piao C; Youn CK; Jin M; Yoon SP; Chang IY; Lee JH; You HJ
Cell Cycle; 2012 Sep; 11(17):3237-49. PubMed ID: 22895183
[TBL] [Abstract][Full Text] [Related]
22. Akt phosphorylation in human chondrocytes is regulated by p53R2 in response to mechanical stress.
Kawakita K; Nishiyama T; Fujishiro T; Hayashi S; Kanzaki N; Hashimoto S; Takebe K; Iwasa K; Sakata S; Nishida K; Kuroda R; Kurosaka M
Osteoarthritis Cartilage; 2012 Dec; 20(12):1603-9. PubMed ID: 22954457
[TBL] [Abstract][Full Text] [Related]
23. P53R2, p53 inducible ribonucleotide reductase gene, correlated with tumor progression of non-small cell lung cancer.
Uramoto H; Sugio K; Oyama T; Hanagiri T; Yasumoto K
Anticancer Res; 2006; 26(2A):983-8. PubMed ID: 16619496
[TBL] [Abstract][Full Text] [Related]
24. A ribonucleotide reductase gene is a transcriptional target of p53 and p73.
Nakano K; Bálint E; Ashcroft M; Vousden KH
Oncogene; 2000 Aug; 19(37):4283-9. PubMed ID: 10980602
[TBL] [Abstract][Full Text] [Related]
25. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
[TBL] [Abstract][Full Text] [Related]
26. p53R2 regulates thioredoxin reductase activity through interaction with TrxR2.
Park SJ; Kim HB; Piao C; Kang MY; Park SG; Kim SW; Lee JH
Biochem Biophys Res Commun; 2017 Jan; 482(4):706-712. PubMed ID: 27866984
[TBL] [Abstract][Full Text] [Related]
27. Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation.
Xue L; Zhou B; Liu X; Heung Y; Chau J; Chu E; Li S; Jiang C; Un F; Yen Y
Cancer Res; 2007 Jan; 67(1):16-21. PubMed ID: 17210678
[TBL] [Abstract][Full Text] [Related]
28. Effect of high-risk human papillomavirus oncoproteins on p53R2 gene expression after DNA damage.
Lembo D; Donalisio M; Cornaglia M; Azzimonti B; Demurtas A; Landolfo S
Virus Res; 2006 Dec; 122(1-2):189-93. PubMed ID: 16872707
[TBL] [Abstract][Full Text] [Related]
29. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
30. Ribonucleotide reductase small subunit p53R2 promotes oral cancer invasion via the E-cadherin/beta-catenin pathway.
Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Yoshida H; Mizuno A
Oral Oncol; 2009 Jun; 45(6):521-5. PubMed ID: 18804405
[TBL] [Abstract][Full Text] [Related]
31. Novel regulators and molecular mechanisms of p53R2 and its disease relevance.
Cho EC; Yen Y
Biochimie; 2016 Apr; 123():81-4. PubMed ID: 26796884
[TBL] [Abstract][Full Text] [Related]
32. The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.
Yousefi B; Rahmati M; Ahmadi Y
Life Sci; 2014 Mar; 99(1-2):14-7. PubMed ID: 24486301
[TBL] [Abstract][Full Text] [Related]
33. Infrequent alteration in the p53R2 gene in human transitional cell carcinoma of the urinary tract.
Hayashi H; Furihata M; Kuwahara M; Kagawa S; Shuin T; Ohtsuki Y
Pathobiology; 2004; 71(2):103-6. PubMed ID: 14707445
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis and functions of p53R2 in zebrafish.
Shang H; Li Q; Feng G; Cui Z
Gene; 2011 Apr; 475(1):30-8. PubMed ID: 21194559
[TBL] [Abstract][Full Text] [Related]
35. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
[TBL] [Abstract][Full Text] [Related]
36. Ribonucleotide reductase subunit p53R2 regulates mitochondria homeostasis and function in KB and PC-3 cancer cells.
Wang X; Liu X; Xue L; Zhang K; Kuo ML; Hu S; Zhou B; Ann D; Zhang S; Yen Y
Biochem Biophys Res Commun; 2011 Jun; 410(1):102-7. PubMed ID: 21640705
[TBL] [Abstract][Full Text] [Related]
37. Akt and p53R2, partners that dictate the progression and invasiveness of cancer.
Yousefi B; Samadi N; Ahmadi Y
DNA Repair (Amst); 2014 Oct; 22():24-9. PubMed ID: 25086499
[TBL] [Abstract][Full Text] [Related]
38. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.
Nardinocchi L; Puca R; Sacchi A; D'Orazi G
Biochem Biophys Res Commun; 2007 Sep; 361(1):249-55. PubMed ID: 17658469
[TBL] [Abstract][Full Text] [Related]
39. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
Quotti Tubi L; Gurrieri C; Brancalion A; Bonaldi L; Bertorelle R; Manni S; Pavan L; Lessi F; Zambello R; Trentin L; Adami F; Ruzzene M; Pinna LA; Semenzato G; Piazza F
J Hematol Oncol; 2013 Oct; 6():78. PubMed ID: 24283803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
